vs

Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and KORU Medical Systems, Inc. (KRMD). Click either name above to swap in a different company.

KORU Medical Systems, Inc. is the larger business by last-quarter revenue ($11.8B vs $7.2M, roughly 1629.7× GREENPOWER MOTOR Co INC.). On growth, KORU Medical Systems, Inc. posted the faster year-over-year revenue change (22.1% vs -11.5%).

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

KORU Medical Systems, Inc. is a specialized medical technology company that designs, manufactures, and distributes innovative ambulatory infusion systems and supporting disposable products. It caters to healthcare providers and patients across home care, clinical trial, and acute care segments worldwide, with a focus on enhancing the safety and comfort of specialty medication delivery.

GP vs KRMD — Head-to-Head

Bigger by revenue
KRMD
KRMD
1629.7× larger
KRMD
$11.8B
$7.2M
GP
Growing faster (revenue YoY)
KRMD
KRMD
+33.6% gap
KRMD
22.1%
-11.5%
GP

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
GP
GP
KRMD
KRMD
Revenue
$7.2M
$11.8B
Net Profit
$-4.7M
Gross Margin
14.6%
61.5%
Operating Margin
31.2%
Net Margin
-65.6%
Revenue YoY
-11.5%
22.1%
Net Profit YoY
-2.1%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GP
GP
KRMD
KRMD
Q1 26
$11.8B
Q4 25
$10.9M
Q3 25
$10.4M
Q2 25
$10.2M
Q1 25
$9.6M
Q4 24
$7.2M
$8.8M
Q3 24
$5.3M
$8.2M
Q2 24
$3.0M
$8.4M
Net Profit
GP
GP
KRMD
KRMD
Q1 26
Q4 25
Q3 25
$-778.0K
Q2 25
$-206.9K
Q1 25
$-1.2M
Q4 24
$-4.7M
Q3 24
$-4.7M
$-1.6M
Q2 24
$-5.4M
$-988.7K
Gross Margin
GP
GP
KRMD
KRMD
Q1 26
61.5%
Q4 25
62.6%
Q3 25
60.2%
Q2 25
63.5%
Q1 25
62.8%
Q4 24
14.6%
62.9%
Q3 24
8.6%
63.4%
Q2 24
7.4%
65.0%
Operating Margin
GP
GP
KRMD
KRMD
Q1 26
31.2%
Q4 25
-5.0%
Q3 25
-8.3%
Q2 25
-3.1%
Q1 25
-12.9%
Q4 24
-18.0%
Q3 24
-20.8%
Q2 24
-14.1%
Net Margin
GP
GP
KRMD
KRMD
Q1 26
Q4 25
Q3 25
-7.5%
Q2 25
-2.0%
Q1 25
-12.1%
Q4 24
-65.6%
Q3 24
-87.9%
-19.3%
Q2 24
-179.8%
-11.7%
EPS (diluted)
GP
GP
KRMD
KRMD
Q1 26
Q4 25
$-0.11
Q3 25
$0.02
Q2 25
$0.00
Q1 25
$0.03
Q4 24
$-0.17
$-0.22
Q3 24
$-0.18
$0.03
Q2 24
$-0.21
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GP
GP
KRMD
KRMD
Cash + ST InvestmentsLiquidity on hand
$621.1K
$8.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.1M
Total Assets
$37.4M
$28.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GP
GP
KRMD
KRMD
Q1 26
$8.8B
Q4 25
$8.9M
Q3 25
$8.5M
Q2 25
$8.1M
Q1 25
$8.7M
Q4 24
$621.1K
$9.6M
Q3 24
$116.9K
$8.8M
Q2 24
$528.3K
$10.5M
Stockholders' Equity
GP
GP
KRMD
KRMD
Q1 26
Q4 25
$17.0M
Q3 25
$16.5M
Q2 25
$16.5M
Q1 25
$16.3M
Q4 24
$2.1M
$16.8M
Q3 24
$4.2M
$17.7M
Q2 24
$8.6M
$18.7M
Total Assets
GP
GP
KRMD
KRMD
Q1 26
$28.6B
Q4 25
$28.2M
Q3 25
$27.1M
Q2 25
$25.5M
Q1 25
$27.2M
Q4 24
$37.4M
$27.2M
Q3 24
$39.4M
$27.4M
Q2 24
$43.5M
$27.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GP
GP
KRMD
KRMD
Operating Cash FlowLast quarter
$-1.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GP
GP
KRMD
KRMD
Q1 26
Q4 25
$1.1M
Q3 25
$65.5K
Q2 25
$-460.3K
Q1 25
$-237.5K
Q4 24
$-1.1M
$939.6K
Q3 24
$-1.3M
$-923.9K
Q2 24
$-3.2M
$11.3K
Free Cash Flow
GP
GP
KRMD
KRMD
Q1 26
Q4 25
$687.0K
Q3 25
$13.0K
Q2 25
$-489.2K
Q1 25
$-680.9K
Q4 24
$896.0K
Q3 24
$-2.0M
Q2 24
$-112.9K
FCF Margin
GP
GP
KRMD
KRMD
Q1 26
Q4 25
6.3%
Q3 25
0.1%
Q2 25
-4.8%
Q1 25
-7.1%
Q4 24
10.1%
Q3 24
-24.5%
Q2 24
-1.3%
Capex Intensity
GP
GP
KRMD
KRMD
Q1 26
Q4 25
3.7%
Q3 25
0.5%
Q2 25
0.3%
Q1 25
4.6%
Q4 24
0.5%
Q3 24
13.2%
Q2 24
1.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons